Osteopore Limited engages in the design, development, and marketing of bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery applications in Singapore, Australia, and internationally. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. The company offers Osteoplug, a bioresorbable implant, which is used for covering trephination burr holes in neurosurgery; and Osteomesh, a bioresorbable implant that is used in craniofacial surgery to repair various types of fractures, such as orbital floor fracture, as well as to fill surgical defects. The company has a collaboration agreement with Livingstone Health Holding Limited to jointly develop new applications and products for regenerating bone and tissue. Osteopore Limited was founded in 2003 and is headquartered in Singapore.
| Market Capitalization | $10.5345 million |
| P/E Ratio | 0 |
| P/E Growth Ratio | |
| Book Value | 0.017 |
| Dividend Per Share | 0 |
| Earnings Per Share | -0.03 |
| EBITDA | -3,998.003 |
| Profit Margin | -2.4789 |
| Operating Margin TTM | -2.4668 |
| Return on Assets TTM | -0.5452 |
| Return on Equity TTM | -1.1301 |
| Revenue TTM | 1,692.387 |
All numbers are in thousands
| Date | Total Revenue | Cost of Revenue | Gross Profit | Total Operating Expenses |
|---|---|---|---|---|
| 2016-12-31 | 204.768 | 82.809 | 121.959 | 1,264.938 |
| 2017-12-31 | 576.777 | 135.244 | 441.533 | 1,076.349 |
| 2018-12-31 | 910.117 | 210.774 | 699.343 | 1,788.171 |
| 2019-12-31 | 414.058 | 123.472 | 290.586 | 2,657.295 |
| 2020-12-31 | 2,229.052 | 549.252 | 1,679.8 | 3,773.97 |
| 2021-12-31 | 1,404.462 | 301.366 | 1,103.096 | 4,933.159 |
| 2022-12-31 | 1,780.848 | 419.098 | 1,361.75 | 5,754.815 |
All numbers are in thousands
| Date | Cash | Total Assets | Total Liabilities | Short Term Debt | Long Term Debt | Common Stock |
|---|---|---|---|---|---|---|
| 2016-12-31 | 28.92 | 858.802 | 2,215.165 | 633.409 | ||
| 2017-12-31 | 32.409 | 335.387 | 2,096.03 | 805.258 | ||
| 2018-12-31 | 4,988.362 | 5,401.751 | 1,168.903 | 665.795 | 20,617.422 | |
| 2019-12-31 | 3,294.809 | 4,284.883 | 1,317.603 | 567.81 | 19,190.063 | |
| 2020-12-31 | 9,027.016 | 10,247.934 | 1,251.589 | 453.993 | 26,066.131 | |
| 2021-12-31 | 4,930.912 | 6,006.291 | 633.4 | 79.94 | 26,066.131 | |
| 2022-12-31 | 2,164.938 | 3,620.481 | 1,513.615 | 45.359 | 27,012.056 |
All numbers are in thousands
| Date | Net Income | Total Cash | Change in Cash | Begin period cash | End period cash | Dividends |
|---|---|---|---|---|---|---|
| 2016-12-31 | -972.768 | -184.273 | 5.273 | |||
| 2017-12-31 | -422.202 | 10.543 | -2.263 | |||
| 2018-12-31 | -847.2 | -322.282 | 526.789 | 0.003 | ||
| 2019-12-31 | -2,397.973 | -1,748.763 | 3,294.806 | 0.003 | 3,294.809 | |
| 2020-12-31 | -1,963.488 | -1,757.723 | 5,732.207 | 3,294.809 | 9,027.016 | |
| 2021-12-31 | -3,620.898 | -3,805.634 | -4,496.841 | 9,027.016 | 4,530.175 | |
| 2022-12-31 | -4,215.598 | -3,997.379 | -3,195.954 | 4,530.175 | 1,334.221 |